Clinical Trials Browser

Phase 1 × OTHER × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00470496 2022-07-25

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Esthesioneuroblastoma, Olfactory

NCT00675233 2018-10-17

Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx

Phase 1 Completed

29 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT01140178 2018-10-16

A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx

Phase 1 Completed

29 enrolled

Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00670397 2016-03-16

Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer

Phase 1 Terminated

11 enrolled

Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

NCT01238042 2014-12-02

Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus

Phase 1 Completed

18 enrolled

Gastrointestinal

Barrett Esophagus

NCT01668823 2014-07-31

Photodynamic Therapy in Treating Patients With Lung Cancer

Phase 1 Completed

17 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT01236443 2014-01-13

Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus

Phase 1 Completed

18 enrolled

Gastrointestinal

Barrett Esophagus

NCT00017485 2011-03-07

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Phase 1 Completed

6 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT00025571 2011-03-07

Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer

Phase 1 Completed

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx

A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx

Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer

Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus

Photodynamic Therapy in Treating Patients With Lung Cancer

Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer